Breast Cancer Clinical Trial

Safety of Pregnancy in BRCA Mutated Breast Cancer Patients

Summary

The present study aims at refining the understanding of the effect of pregnancy on breast cancer outcomes in the specific population of BRCA mutated patients with known history of breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of invasive breast cancer between January 2000 and December 2012;
Breast cancer diagnosis at the age of ≤ 40 years;
Known presence of germline BRCA mutation.

Exclusion Criteria:

Known BRCA mutation with no diagnosis of invasive breast cancer;
Diagnosis of ovarian cancer or other malignancies with no history of invasive breast cancer;
Diagnosis of hereditary or familiar invasive breast cancer without BRCA mutation or with BRCA genes not tested.

Study is for people with:

Breast Cancer

Estimated Enrollment:

2200

Study ID:

NCT03673306

Recruitment Status:

Active, not recruiting

Sponsor:

Jules Bordet Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Dana-Farber Cancer Institute
Boston Massachusetts, 02215, United States
Cliniques Universitaires Saint-Luc UCL
Brussels , , Belgium
Institut Jules Bordet
Brussels , , Belgium
University Hospitals Leuven, KU Leuven
Leuven , , Belgium
Cancer Institute ICESP
São Paulo , , Brazil
Bergonie Institute
Bordeaux , , France
Leon Berard Cancer Center
Lyon , , France
Hopital Saint Louis
Paris , , France
Institut Curie
Paris , , France
Centre Henri Becquerel
Rouen , , France
Institut Gustave Roussy
Villejuif , , France
Sharett Institute of Oncology - Hadassah Hebrew University Medical Center
Jerusalem , , Israel
Sheba Medical Center
Tel Aviv , , Israel
Tel Aviv Sourasky Medical Center
Tel Aviv , , Israel
Oncological Center CRO
Aviano , , Italy
Azienda Ospedaliera "Papa Giovanni XXIII"
Bergamo , , Italy
Candiolo Cancer Center (IRCCS)
Candiolo , , Italy
Policlinico San Martino - IRCCS per l'Oncologia
Genova , , Italy
European Institute of Oncology
Milan , , Italy
Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia
Modena , , Italy
IOV (Istituto Oncologico Veneto)
Padova , , Italy
IRCCS Policlinico San Matteo
Pavia , , Italy
AOU Policlinico Umberto I
Roma , , Italy
Instituto Nacional de Cancerologia
Mexico City , , Mexico
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Warsaw , , Poland
Hospital de Santa Maria and Instituto de Medicina Molecular of the Faculty of Medicine of the University of Lisbon
Lisbon , , Portugal
Vall D'Hebron University Hospital
Barcelona , , Spain
Hospital Universitari Son Espases Palma
Palma De Mallorca , , Spain
INCLIVA, University Hospital of Valencia
Valencia , , Spain
Oncology Institute of Southern Switzerland
Lugano , , Switzerland

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

2200

Study ID:

NCT03673306

Recruitment Status:

Active, not recruiting

Sponsor:


Jules Bordet Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider